Home   Contact Us   Sitemap
 



 Financial & IR Update  News Update  Annual Report 2014-15
 
Indoco Remedies Q3 sales rises 19.6% as domestic business bounces back
Unaudited Standalone Financial Results for the Quarter and Nine Months ended 31st December, 2015 - Q3 FY16
Management Discussion & Analysis for the Third Quarter FY16
 
Indoco Remedies achieves a milestone of Rs. 1000 Cr.
Indoco Remedies receives USFDA nod for solid dosages Plant I in Goa - March 21, 2016
Trxade Group Signs Agreement to Distribute Glaucoma Drug in U.S., GlobeNewswire.com - November 30, 2015
more

Disclaimer